Search clinical trials for: IMR-687

Total 137 results

Imara, Inc.

Withdrawn

Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction (SP9In-HFpEF)

Heart Failure With Preserved Ejection Fraction
Imara, Inc.

Active, not recruiting

An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia

Sickle Cell Disease

United States, United Kingdom
Imara, Inc.

Completed

A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)

Sickle Cell Disease

United States, United Kingdom
Imara, Inc.

Terminated

A Study of IMR-687 in Subjects With Sickle Cell Disease

Sickle Cell Disease

United States, Oman, Italy, United Kingdom, Lebanon, Greece, Morocco, Tunisia, Ghana, Kenya, Netherlands, Senegal, Uganda
Imara, Inc.

Terminated

A Study of IMR-687 in Subjects With Beta Thalassemia

β Thalassemia

Israel, France, Malaysia, Turkey, Denmark, Georgia, Greece, Italy, Lebanon, Morocco, Netherlands, Tunisia, United Kingdom
Imara, Inc.
Quintiles, Inc.

Completed

A Study of IMR-687 in Healthy Adult Volunteers

Sickle Cell Disease | Sickle Beta 0 Thalassemia | Sickle-Cell; Hb-SC

United States
ThromboGenics

Completed

A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)

Diabetes Mellitus | Diabetic Retinopathy | Diabetic Macular Edema

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents

Allergic Reactions
Pro Bono Bio
International Medical Research - Partner GmbH

Unknown

Study of FLEXISEQ® for Treatment of Osteoarthritis of the Knee in NSAID-compromised Patients (OANIT)

Osteoarthritis

Germany
Consorzio Futuro in Ricerca

Active, not recruiting

IMR Evaluation in Patients With Coronary Sinus Reducer Implantation (INROAD Study) (INROAD)

Refractory Angina Pectoris

Italy
University of Washington

Completed

Integration of Illness Management and Recovery Within ACT (ACT+IMR)

Schizophrenia | Bipolar Disorder | Severe Mental Illness
University Hospital, Akershus

Terminated

Young People and Illness Management and Recovery (IMR)

Bipolar Disorder | Psychosis | Other Diagnoses and Conditions

Norway
Stanford University
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast

Head and Neck Cancer | Head and Neck Cancers

United States
Second Affiliated Hospital, School of Medicine,...
RenJi Hospital; Shengjing Hospital

Completed

Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction

Acute Myocardial Infarction (AMI)

China
Mental Health Centre Copenhagen
Mental Health Services in the Capital Region, Denmark; The Danish Health Fund

Completed

Illness Management and Recovery (IMR) in Danish Community Mental Health Centres (IMR)

Schizophrenia | Bipolar Disorder

Denmark
Oxurion

Terminated

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. (INTEGRAL)

Diabetes Mellitus | Diabetic Retinopathy | Diabetic Macular Edema

Latvia, Lithuania, United States, Hungary, Estonia
Samsung Medical Center
RainMed Medical

Completed

Prognostic Implication of Angiography-Derived IMR in STEMI Patients

Acute ST-segment Elevation Myocardial Infarction
University Hospital, Akershus
Helse Sor-Ost; Romeriksprosjektet

Completed

Implementation of Illness Management and Recovery in Mental Health Services

Mental Disorders | Mood Disorders | Schizophrenia | Bipolar Disorder | Affective Disorders, Psychotic

Norway
Federico II University
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Fondazione... and other collaborators

Recruiting

Characterization of Different Phenotypes of Microvascular Dysfunction and Their Impact on Angina Severity in Patients With Chronic Angina in the Absence of Obstructive Coronary Artery Disease. (MiVa)

Angina CCS Classe II-IV - IMR, RFR, FFR,CFR

Italy
Otsuka Pharmaceutical Development & Commercialization...
Sumitomo Pharma Co., Ltd.; Sumitomo Pharma America, Inc.

Recruiting

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Enrolling by invitation

Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

Immunoglobulin A Nephropathy

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder

Post Traumatic Stress Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)

Borderline Personality Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Active, not recruiting

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...

Active, not recruiting

Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)

Immunoglobulin A Nephropathy

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Alzheimer's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Alzheimer Dementia | Agitation Associated With Alzheimer's Dementia

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

Attention-deficit Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Epilepsy

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Coronary Microcirculation Assessment After Primary Angioplasty in Myocardial Infarction (NATHANAEL)

STEMI - ST Elevation Myocardial Infarction

France
Abbott Medical Devices

Completed

Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)

STEMI | Multi Vessel Coronary Artery Disease

Italy
Hospices Civils de Lyon

Completed

Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy? (R2D2)

Type 2 Diabetes Mellitus

France
VA Office of Research and Development
Indiana University; Dartmouth College

Completed

Illness Management and Recovery for Veterans With Severe Mental Illness

Schizophrenia | Schizo-affective Disorder

United States
Aarhus University Hospital Skejby
Department of Nuclear Medicine, Aarhus University Hospital

Active, not recruiting

The Association Between Catheter-based Absolute Coronary Flow and Resistance and 15O-H2O Positron Emission Tomography Scan Based Absolute Myocardial Blood Flow in the Coronary Artery Territory (FLOW3)

Coronary Artery Disease

Denmark
Aurelia Hospital

Not yet recruiting

Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale (IMPRESSION)

Coronary Microvascular Dysfunction | Resistant Hypertension | Hypertensive Heart Disease
Helios Health Institute GmbH
Heart Center Leipzig - University Hospital

Recruiting

Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis (CHOICE-FR)

Coronary Artery Stenosis | Transcatheter Aortic Valve Implantation

Germany
Shanghai Zhongshan Hospital
Shanghai 10th People's Hospital

Not yet recruiting

Diagnostic and Prognostic Value of Angiography-derived IMR (CHART-MiCro)

Myocardial Ischemia | Coronary Microvascular Dysfunction

China
Yale University
National Institute of Mental Health (NIMH)

Completed

Culturally Responsive Person-Centered Care for Psychosis

Psychotic Disorders

United States
Central South University

Unknown

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR (ARMYDA-IMR)

Stable Angina | Unstable Angina | Acute Non-ST-segment Elevation Myocardial Infarction

China
National Heart Centre Singapore

Unknown

Optical Coherence Tomography in STEMI

STEMI

Singapore
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder (JUNIPER)

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
Click Therapeutics, Inc.

Completed

Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder (MIRAI)

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD

Post Traumatic Stress Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States

Search clinical trials for: IMR-687

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations